Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.66), $0.06 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Oscar Health Inc. sees FY2024 revenue of $8.3-8.4 billion, versus the consensus of $7.265 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.